Sector ratings Takeda Pharmaceutical Company Limited

Equities

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-01-19 EST			5-day change	1st Jan Change
5,106.00 ^JPY	+0.65%		+0.51%	+5.60%

01-15	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
01-13	Oncolytics Biotech Inc. Appoints Yujun Wu as Vice President, Head of Biostatistics	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.71B		AA
ELI LILLY AND COMPANY	930B		A
JOHNSON & JOHNSON	527B		BBB
ABBVIE INC.	379B		AA
ROCHE HOLDING AG	371B		AA
ASTRAZENECA PLC	292B		A
NOVARTIS AG	276B		AAA
MERCK & CO., INC.	270B		A
NOVO NORDISK A/S	268B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	155B		AAA
PFIZER INC.	146B		BBB
SANOFI	113B		A
BRISTOL-MYERS SQUIBB COMPANY	112B		A
VERTEX PHARMACEUTICALS INCORPORATED	112B		AA
GSK PLC	97.55B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	85.93B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	59.15B		AA
ALNYLAM PHARMACEUTICALS, INC.	47.46B		AA	-
Average	226.7B		AA
Weighted average by Cap.			AA